cancer cell metabolism modulator OMT-111
Term · Oncology and biomedicine · MLC-T-ONC-012217
A cancer cell metabolism modulator, with potential antineoplastic activity. Upon administration, OMT-111 inhibits pyruvate dehydrogenase kinase (PDH), resulting in the activation of the citric acid cycle in mitochondria, which leads to the degradation of hypoxia-inducible factor 1-alpha (HIF1A). This may result in decreased expression of HIF1A downstream target genes important to tumor growth and survival, a reduction in tumor cell proliferation, and the induction of tumor cell apoptosis. OMT-111 may stimulate apoptosis in cancer cells by restoring normal mitochondrial-induced apoptotic signaling.
| Identifier | MLC-T-ONC-012217 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012217",
"term": "cancer cell metabolism modulator OMT-111",
"field": "Oncology and biomedicine",
"definition": "A cancer cell metabolism modulator, with potential antineoplastic activity. Upon administration, OMT-111 inhibits pyruvate dehydrogenase kinase (PDH), resulting in the activation of the citric acid cycle in mitochondria, which leads to the degradation of hypoxia-inducible factor 1-alpha (HIF1A). This may result in decreased expression of HIF1A downstream target genes important to tumor growth and survival, a reduction in tumor cell proliferation, and the induction of tumor cell apoptosis. OMT-111 may stimulate apoptosis in cancer cells by restoring normal mitochondrial-induced apoptotic signaling.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cancer-cell-metabolism-modulator-omt-111/"
}
Record 4,070 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.